EGFR and cancer: EGFR is a rational target for cancer therapy, because its overexpression plays an important oncogenic role in a variety of solid tumors, such as head and neck, breast, lung, and colorectal cancer (Ang et al., 2002; Reis‐Filho et al., 2005; Selvaggi et al., 2004; Repetto et al., 2005).